Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20334351rdf:typepubmed:Citationlld:pubmed
pubmed-article:20334351lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:20334351lifeskim:mentionsumls-concept:C0302912lld:lifeskim
pubmed-article:20334351lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:20334351lifeskim:mentionsumls-concept:C0068882lld:lifeskim
pubmed-article:20334351lifeskim:mentionsumls-concept:C1721124lld:lifeskim
pubmed-article:20334351pubmed:issue8lld:pubmed
pubmed-article:20334351pubmed:dateCreated2010-4-12lld:pubmed
pubmed-article:20334351pubmed:abstractTextFive-coordinate oxorhenium(V) anions with redox-active catecholate ligands deoxygenate stable nitroxyl radicals, including TEMPO(*), to afford dioxorhenium(VII) complexes and aminyl radical-derived products. A structural homologue with redox-inert oxalate ligands does not react with TEMPO(*). Redox-active ligands are proposed to lower the kinetic barrier to TEMPO(*) deoxygenation by giving access to 1e(-) redox steps that are crucial for the formation and stabilization of intermediate species.lld:pubmed
pubmed-article:20334351pubmed:languageenglld:pubmed
pubmed-article:20334351pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20334351pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:20334351pubmed:monthAprlld:pubmed
pubmed-article:20334351pubmed:issn1520-510Xlld:pubmed
pubmed-article:20334351pubmed:authorpubmed-author:SoperJake DJDlld:pubmed
pubmed-article:20334351pubmed:authorpubmed-author:LippertCamero...lld:pubmed
pubmed-article:20334351pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20334351pubmed:day19lld:pubmed
pubmed-article:20334351pubmed:volume49lld:pubmed
pubmed-article:20334351pubmed:ownerNLMlld:pubmed
pubmed-article:20334351pubmed:authorsCompleteYlld:pubmed
pubmed-article:20334351pubmed:pagination3682-4lld:pubmed
pubmed-article:20334351pubmed:year2010lld:pubmed
pubmed-article:20334351pubmed:articleTitleDeoxygenation of nitroxyl radicals by oxorhenium(V) complexes with redox-active ligands.lld:pubmed
pubmed-article:20334351pubmed:affiliationSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, USA.lld:pubmed
pubmed-article:20334351pubmed:publicationTypeJournal Articlelld:pubmed